Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Natural Health Trends | NHTC | Nov 29, 2024 | 5.44 | -0.73 |
Natural Resource Partners LP Unit | NRP | Nov 29, 2024 | 109.49 | -0.01 |
Nature Wood Group ADR | NWGL | Nov 29, 2024 | 1.36 | -3.55 |
Natures Miracle Holding | NMHI | Nov 29, 2024 | 2.57 | -8.54 |
Natures Sunshine Products | NATR | Nov 29, 2024 | 16.24 | +0.56 |
Natuzzi ADR | NTZ | Nov 29, 2024 | 4.54 | -3.40 |
NatWest ADR | NWG | Nov 29, 2024 | 10.34 | +3.09 |
Nauticus Robotics | KITT | Nov 29, 2024 | 1.21 | +8.04 |
Nautilus Biotechnology | NAUT | Nov 29, 2024 | 2.24 | -2.61 |
Navidea Biopharmaceuticals | NAVB | Nov 29, 2024 | 0.00 | -90.00 |
Navient | NAVI | Nov 29, 2024 | 15.58 | +1.70 |
Navigator Holdings | NVGS | Nov 29, 2024 | 15.66 | -0.38 |
Navios Maritime Partners LP Unit | NMM | Nov 29, 2024 | 48.44 | +1.11 |
Navitas Semiconductor | NVTS | Nov 29, 2024 | 2.75 | +11.79 |
Naya Biosciences | NAYA | Nov 29, 2024 | 0.98 | 0.00 |
Nayax | NYAX | Nov 29, 2024 | 29.63 | -0.37 |
NB Bancorp | NBBK | Nov 29, 2024 | 20.14 | -0.20 |
NBT Bancorp | NBTB | Nov 29, 2024 | 50.12 | +0.08 |
Ncino | NCNO | Nov 29, 2024 | 41.99 | +0.26 |
NCR | VYX | Nov 29, 2024 | 14.51 | +0.14 |
NCR Atleos When Issued | NATL | Nov 29, 2024 | 32.81 | +0.40 |
NCS Multistage | NCSM | Nov 29, 2024 | 20.94 | -7.18 |
Nebius Group | NBIS | Nov 29, 2024 | 21.99 | 0.00 |
Nektar Therapeutics | NKTR | Nov 29, 2024 | 1.14 | +0.89 |
Nelnet | NNI | Nov 29, 2024 | 108.92 | +0.15 |
Neogen | NEOG | Nov 29, 2024 | 14.18 | +0.28 |
NeoGenomics | NEO | Nov 29, 2024 | 17.73 | -0.06 |
Neonode | NEON | Nov 29, 2024 | 8.20 | +4.46 |
NeoVolta | NEOV | Nov 29, 2024 | 5.09 | +2.62 |
Nephros | NEPH | Nov 29, 2024 | 1.55 | +2.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.